바로가기메뉴

본문 바로가기 주메뉴 바로가기

Tuberculosis & Respiratory Diseases

Article Contents

Prev Next
e-Submission

Vol.78 No.3
Citation Share

Vitamin D Status in South Korean Military Personnel with Acute Eosinophilic Pneumonia: A Pilot Study

Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2015, v.78 no.3, pp.232-238





& (2015). Vitamin D Status in South Korean Military Personnel with Acute Eosinophilic Pneumonia: A Pilot Study. Tuberculosis & Respiratory Diseases, 78(3), 232-238.
  • Downloaded
  • Viewed
PDF Download

Abstract

Background: A relationship between low vitamin D levels and the development or outcomes of respiratory diseases has been identified. However, there is no data on the vitamin D status in patients with acute eosinophilic pneumonia (AEP). We evaluated the vitamin D status in patients with AEP among South Korean military personnel. Methods: We prospectively compared the serum levels of total 25-hydroxyvitamin D [25(OH)D], 25(OH)D3, and 25(OH)D2 among patients with AEP, pulmonary tuberculosis (PTB), and community-acquired pneumonia (CAP). Results: In total, 65 patients with respiratory diseases, including AEP (n=24), PTB (n=19), and CAP (n=22), were identified. Of the 24 patients with AEP, 2 (8%) had deficient total 25(OH)D levels (<10 ng/mL), 17 (71%) had insufficient total 25(OH)D levels (≥10 to <30 ng/mL), and only 5 (21%) had sufficient total 25(OH)D levels (≥30 to <100 ng/mL). The difference in the total 25(OH)D levels among patients with AEP, PTB, and CAP was not statistically significant (p=0.230). The median levels of total 25(OH)D, 25(OH)D3, and 25(OH)D2 were 22.84, 22.84, and 0.00 ng/mL, respectively, and no differences in the 25(OH)D level were present among patients with AEP, PTB, and CAP with the exception of the total 25(OH)D level between patients with AEP and PTB (p=0.042). Conclusion: We have shown that low vitamin D levels are frequently found in patients with AEP and are comparable with those in patients with PTB and CAP.

keywords
Deficiency, Pulmonary Eosinophilia, Pneumonia, Vitamin D

Reference

1.

1. Holick MF. (2007), Vitamin D deficiency. N Engl J Med, 357,266- 81.

2.

2. Kim JH., Park JS., Cho YJ., Yoon HI., Song JH., Lee CT. (2014), Low serum 25-hydroxyvitamin D level: an independent risk factor for tuberculosis?, Clin Nutr, 33,1081-6.

3.

3. Salahuddin N., Ali F., Hasan Z., Rao N., Aqeel M., Mahmood F. (2013), Vitamin D accelerates clinical recovery from tuberculosis: results of the SUCCINCT Study [Supplementary Cholecalciferol in recovery from tuberculosis]. A randomized, placebocontrolled, clinical trial of vitamin D supplementation in patients with pulmonary tuberculosis’. BMC Infect Dis, 13, 22.

4.

4. Hong JY., Kim SY., Chung KS., Kim EY., Jung JY., Park MS. (2014), Association between vitamin D deficiency and tuberculosis in a Korean population. Int J Tuberc Lung Dis, 18,73-8.

5.

5. Jolliffe DA., Griffiths CJ., Martineau AR. (2013), Vitamin D in the prevention of acute respiratory infection: systematic review of clinical studies. J Steroid Biochem Mol Biol, 136,321-9.

6.

6. Bergman P., Lindh AU., Bjorkhem-Bergman L., Lindh JD. (2013), Vitamin D and respiratory tract infections: a systematic review and meta-analysis of randomized controlled trials. PLoS One, 8,e65835.

7.

7. Aregbesola A., Voutilainen S., Nurmi T., Virtanen JK., Ronkainen K., Tuomainen TP. (2013), Serum 25-hydroxyvitamin D3 and the risk of pneumonia in an ageing general population. J Epidemiol Community Health, 67,533-6.

8.

8. Remmelts HH., van de Garde EM., Meijvis SC., Peelen EL., Damoiseaux JG., Grutters JC. (2012), Addition of vitamin D status to prognostic scores improves the prediction of outcome in community-acquired pneumonia. Clin Infect Dis, 55, 1488-94.

9.

9. Janssens W., Lehouck A., Carremans C., Bouillon R., Mathieu C., Decramer M. (2009), Vitamin D beyond bones in chronic obstructive pulmonary disease: time to act. Am J Respir Crit Care Med, 179,630-6.

10.

10. Janssens W., Bouillon R., Claes B., Carremans C., Lehouck A., Buysschaert I. (2010), Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene. Thorax, 65,215-20.

11.

11. Brehm JM., Schuemann B., Fuhlbrigge AL., Hollis BW., Strunk RC., Zeiger RS. (2010), Serum vitamin D levels and severe asthma exacerbations in the Childhood Asthma Management Program study. J Allergy Clin Immunol, 126,52-8.e5.

12.

12. Cantorna MT., Hayes CE., DeLuca HF. (1996), 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc Natl Acad Sci U S A, 93,7861-4.

13.

13. Cantorna MT., Munsick C., Bemiss C., Mahon BD. (2000), 1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. J Nutr, 130,2648-52.

14.

14. Mahon BD., Wittke A., Weaver V., Cantorna MT. (2003), The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells. J Cell Biochem, 89,922-32.

15.

15. Lee JE., Rhee CK., Lim JH., Lee SM., Shim YS., Lee CT. (2012), Fraction of exhaled nitric oxide in patients with acute eosinophilic pneumonia. Chest, 141,1267-72.

16.

16. Rhee CK., Min KH., Yim NY., Lee JE., Lee NR., Chung MP. (2013), Clinical characteristics and corticosteroid treatment of acute eosinophilic pneumonia. Eur Respir J, 41,402-9.

17.

17. Jhun BW., Kim SJ., Kim K., Lee JE. (2014), Clinical implications of initial peripheral eosinophilia in acute eosinophilic pneumonia. Respirology, 19,1059-65.

18.

18. Philit F., Etienne-Mastroianni B., Parrot A., Guerin C., Robert D., Cordier JF. (2002), Idiopathic acute eosinophilic pneumonia: a study of 22 patients. Am J Respir Crit Care Med, 166,1235-9.

19.

19. Jhun BW., Kim SJ., Kim K., Lee JE., Hong DJ. (2014), Clinical implications of correlation between peripheral eosinophil count and serum levels of IL-5 and tryptase in acute eosinophilic pneumonia. Respir Med, 108,1655-62.

20.

20. World Health Organization. (2003), Treatment of tuberculosis: guidelines for national programmes. 3rd ed. Geneva: World Health Organization.

21.

21. Lee SW., Jang YS., Park CM., Kang HY., Koh WJ., Yim JJ. (2010), The role of chest CT scanning in TB outbreak investigation. Chest, 137,1057-64.

22.

22. Carratala J., Fernandez-Sabe N., Ortega L., Castellsague X., Roson B., Dorca J. (2005), Outpatient care compared with hospitalization for community-acquired pneumonia: a randomized trial in low-risk patients. Ann Intern Med, 142,165-72.

23.

23. Ganmaa D., Giovannucci E., Bloom BR., Fawzi W., Burr W., Batbaatar D. (2012), Vitamin D, tuberculin skin test conversion, and latent tuberculosis in Mongolian school-age children: a randomized, double-blind, placebo-controlled feasibility trial. Am J Clin Nutr, 96,391-6.

24.

24. Bergman P., Norlin AC., Hansen S., Rekha RS., Agerberth B., Bjorkhem-Bergman L. (2012), Vitamin D3 supplementation in patients with frequent respiratory tract infections: a randomised and double-blind intervention study. BMJ Open, 2,e001663.

25.

25. Quraishi SA., Bittner EA., Christopher KB., Camargo CA Jr. (2013), Vitamin D status and community-acquired pneumonia: results from the third National Health and Nutrition Examination Survey. PLoS One, 8,e81120.

26.

26. Badesch DB., King TE Jr., Schwarz MI. (1989), Acute eosinophilic pneumonia: a hypersensitivity phenomenon?, Am Rev Respir Dis, 139,249-52.

27.

27. Imokawa S., Sato A., Hayakawa H., Toyoshima M., Taniguchi M., Chida K. (1996), Possible involvement of an environmental agent in the development of acute eosinophilic pneumonia. Ann Allergy Asthma Immunol, 76,419-22.

28.

28. Rom WN., Weiden M., Garcia R., Yie TA., Vathesatogkit P., Tse DB. (2002), Acute eosinophilic pneumonia in a New York City firefighter exposed to World Trade Center dust. Am J Respir Crit Care Med, 166,797-800.

29.

29. Uchiyama H., Suda T., Nakamura Y., Shirai M., Gemma H., Shirai T. (2008), Alterations in smoking habits are associated with acute eosinophilic pneumonia. Chest, 133,1174-80.

30.

30. Yoshimoto T., Mizutani H., Tsutsui H., Noben-Trauth N., Yamanaka K., Tanaka M. (2000), IL-18 induction of IgE: dependence on CD4+ T cells, IL-4 and STAT6. Nat Immunol, 1, 132-7.

31.

31. Mato N., Bando M., Kusano A., Hirano T., Nakayama M., Uto T. (2013), Clinical significance of interleukin 33 (IL-33) in patients with eosinophilic pneumonia. Allergol Int, 62,45-52.

32.

32. Adams JS., Liu PT., Chun R., Modlin RL., Hewison M. (2007), Vitamin D in defense of the human immune response. Ann N Y Acad Sci, 1117,94-105.

33.

33. Bartley J. (2010), Vitamin D, innate immunity and upper respiratory tract infection. J Laryngol Otol, 124,465-9.

34.

34. Choi HS., Oh HJ., Choi H., Choi WH., Kim JG., Kim KM. (2011), Vitamin D insufficiency in Korea--a greater threat to younger generation: the Korea National Health and Nutrition Examination Survey (KNHANES) 2008. J Clin Endocrinol Metab, 96,643-51.

Tuberculosis & Respiratory Diseases

e-Submission OA Policy